130 related articles for article (PubMed ID: 38554197)
1. Faggot cells observed in a patient with myelodysplastic syndrome with increased blasts.
Ito M; Fukushima N
Int J Hematol; 2024 May; 119(5):476-478. PubMed ID: 38554197
[No Abstract] [Full Text] [Related]
2. Chronic myeloid leukemia in lymphoid blast crisis.
Cherian S; Walter RB
Eur J Haematol; 2014; 92(5):458. PubMed ID: 24215714
[No Abstract] [Full Text] [Related]
3. Do peripheral blasts count in myelodysplastic syndromes?
Alhan C; Westers TM; Ossenkoppele GJ; van de Loosdrecht AA
Leuk Res; 2009 Feb; 33(2):209-11. PubMed ID: 18640720
[No Abstract] [Full Text] [Related]
4. Peripheral acute leukemia: high peripheral but low-marrow blast count.
Cason JD; Trujillo JM; Estey EH; Huh YO; Freireich EJ; Stass SA
Blood; 1989 Oct; 74(5):1758-61. PubMed ID: 2790200
[TBL] [Abstract][Full Text] [Related]
5. Multilineage dysplasia without increased blasts identifies a poor prognosis subset of myelodysplastic syndromes.
Balduini CL; Guarnone R; Pecci A; Centenara E; Ascari E
Leukemia; 1998 Oct; 12(10):1655-6. PubMed ID: 9766515
[No Abstract] [Full Text] [Related]
6. Granulocyte colony-stimulating factor and interleukin-6 production by myelodysplastic syndrome blasts.
Kobayashi K; Yokote T; Akioka T; Hara S; Hiraoka N; Oka S; Nakayama S; Miyoshi T; Hirata Y; Takubo T; Tsuji M; Hanafusa T
Leuk Lymphoma; 2008 Mar; 49(3):589-91. PubMed ID: 18297540
[No Abstract] [Full Text] [Related]
7. Interactions and relevance of blast percentage and treatment strategy among younger and older patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS).
DiNardo CD; Garcia-Manero G; Pierce S; Nazha A; Bueso-Ramos C; Jabbour E; Ravandi F; Cortes J; Kantarjian H
Am J Hematol; 2016 Feb; 91(2):227-32. PubMed ID: 26799610
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic criteria for hypocellular acute leukemia: a clinical entity distinct from overt acute leukemia and myelodysplastic syndrome.
Nagai K; Kohno T; Chen YX; Tsushima H; Mori H; Nakamura H; Jinnai I; Matsuo T; Kuriyama K; Tomonaga M; Bennett JM
Leuk Res; 1996 Jul; 20(7):563-74. PubMed ID: 8795690
[TBL] [Abstract][Full Text] [Related]
9. Impact of marrow blasts percentage on high-grade myelodysplastic syndrome assessed using revised international prognostic scoring system.
Alkharabsheh O; Patnaik MM; Gangat N; Begna KH; Alkhateeb HB; Shah MV; Hogan WJ; He R; Greipp P; Nguyen PL; Litzow MR; Al-Kali A
Ann Hematol; 2020 Mar; 99(3):513-518. PubMed ID: 31974678
[TBL] [Abstract][Full Text] [Related]
10. Having a higher blast percentage in circulation than bone marrow: clinical implications in myelodysplastic syndrome and acute lymphoid and myeloid leukemias.
Amin HM; Yang Y; Shen Y; Estey EH; Giles FJ; Pierce SA; Kantarjian HM; O'Brien SM; Jilani I; Albitar M
Leukemia; 2005 Sep; 19(9):1567-72. PubMed ID: 16049515
[TBL] [Abstract][Full Text] [Related]
11. Prognosis in patients with MDS or AML and bone marrow blasts between 10% and 30% is not associated with blast counts but depends on cytogenetic and molecular genetic characteristics.
Bacher U; Kern W; Alpermann T; Schnittger S; Kohlmann A; Klein HU; Dugas M; Haferlach C; Haferlach T
Leukemia; 2011 Aug; 25(8):1361-4. PubMed ID: 21494258
[No Abstract] [Full Text] [Related]
12. Selective blast cell reduction in elderly patients with acute myeloid leukemia secondary to myelodysplastic syndrome treated with methylprednisolone.
Suzuki K; Ohishi K; Sekine T; Masuya M; Katayama N
Int J Hematol; 2007 May; 85(4):344-9. PubMed ID: 17483080
[TBL] [Abstract][Full Text] [Related]
13. Leukocyte alkaline phosphatase score correlation with bone marrow blast percentage in myelodysplastic syndrome.
Lipshitz J; Limaye S; Patel D
Acta Haematol; 2010; 124(3):179-81. PubMed ID: 20962518
[No Abstract] [Full Text] [Related]
14. Transient increase in blasts mimicking acute leukemia and progressing myelodysplasia in patients receiving growth factor.
Meyerson HJ; Farhi DC; Rosenthal NS
Am J Clin Pathol; 1998 Jun; 109(6):675-81. PubMed ID: 9620023
[TBL] [Abstract][Full Text] [Related]
15. Intracellular ROS profile in hematopoietic progenitors of MDS patients: association with blast count and iron overload.
Chan LSA; Gu LC; Leitch HA; Wells RA
Hematology; 2021 Dec; 26(1):88-95. PubMed ID: 34000978
[No Abstract] [Full Text] [Related]
16. [Successful treatment of acute non-lymphoblastic leukemia from myelodysplastic syndrome by combination of human macrophage colony-stimulating factor (M-CSF) and low dose cytosine arabinoside: M-CSF-induced proliferation and tyrosine phosphorylation in leukemic blasts].
Hagiwara S; Yuo A; Nagai M; Takezako N; Soda Y; Miwa A; Togawa A; Takaku F
Rinsho Ketsueki; 1996 Nov; 37(11):1259-64. PubMed ID: 8960658
[TBL] [Abstract][Full Text] [Related]
17. A myelodysplastic syndrome preceding acute lymphoblastic leukaemia.
Berneman ZN; Van Bockstaele D; De Meyer P; Van der Planken M; Vertessen F; De Bock R; Peetermans ME
Br J Haematol; 1985 Jun; 60(2):353-4. PubMed ID: 3859321
[TBL] [Abstract][Full Text] [Related]
18. Improving Revised International Prognostic Scoring System Pre-Allogeneic Stem Cell Transplantation Does Not Translate Into Better Post-Transplantation Outcomes for Patients with Myelodysplastic Syndromes: A Single-Center Experience.
Alzahrani M; Power M; Abou Mourad Y; Barnett M; Broady R; Forrest D; Gerrie A; Hogge D; Nantel S; Sanford D; Song K; Sutherland H; Toze C; Nevill T; Narayanan S
Biol Blood Marrow Transplant; 2018 Jun; 24(6):1209-1215. PubMed ID: 29474870
[TBL] [Abstract][Full Text] [Related]
19. Interobserver variance in myelodysplastic syndromes with less than 5 % bone marrow blasts: unilineage vs. multilineage dysplasia and reproducibility of the threshold of 2 % blasts.
Font P; Loscertales J; Soto C; Ricard P; Novas CM; Martín-Clavero E; López-Rubio M; Garcia-Alonso L; Callejas M; Bermejo A; Benavente C; Ballesteros M; Cedena T; Calbacho M; Urbina R; Villarrubia J; Gil S; Bellón JM; Diez-Martin JL; Villegas A
Ann Hematol; 2015 Apr; 94(4):565-73. PubMed ID: 25387664
[TBL] [Abstract][Full Text] [Related]
20. [Pattern analytic investigations of blast cells in myelodysplastic syndrome and secondary acute myeloid leukemia].
Baumann I; Harms H; Kuse R; Feller AC; Müller-Hermelink HK
Verh Dtsch Ges Pathol; 1990; 74():135-8. PubMed ID: 1708571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
